The Helldivers 2 Into the Unjust update introduces the Bastion Tank and brings back the LAS-16 Trident, a beloved weapon from ...

(RTTNews) - Biotechnology company Q32 Bio, Inc. (QTTB) announced Monday it has sold its Phase 2 complement inhibitor, ADX-097, to Akebia Therapeutics, Inc. (AKBA). ADX-097, the lead product candidate ...

-- $12 million in upfront and guaranteed near-term milestone payments expected to extend cash runway into the second half of 2027 -- -- Eligible to receive up to a total of $592 million including the ...

It had taken Bungie seven years of trial and error to land on systems for loot, leveling, investment and currency in Destiny 2 that were somewhat balanced and ...

DECATUR, Ill. (WAND) — A new addition to a Decatur park offers an opportunity for cycling growth among young people. The Decatur Park District announced the opening of a brand new bicycle skills ...

When it comes to the Los Angeles Dodgers, few players are as consistent as catcher Will Smith. Originally drafted by the team in the first round of 2016 before making his debut in 2019, Smith has ...

SEOUL, South Korea--(BUSINESS WIRE)--ImmunAbs Inc., a clinical-stage biotech specializing in developing antibody therapeutics, today announced that the U.S. Food and Drug Administration has cleared ...

The Vikings aren't messing around when it comes to fixing a running game that has struggled during the first three years of ...

Despite the failure of an eczema trial in December, Q32 Bio is sticking with bempikibart. But a phase 2-stage complement inhibitor and a number of the biotech’s “valued colleagues” won’t be so lucky.

After sending Spencer Rattler to the NFL in the offseason, South Carolina head coach Shane Beamer says the Gamecocks will look different at the quarterback spot in 2024. And former Auburn quarterback ...

Complement activation is considered to contribute to the pathogenesis of severe SARS-CoV-2 infection, mainly by generating potent immune effector mechanisms including a strong inflammatory response.